Introduction: Pharmacogenomics (PGx), an essential component of Personalized Medicine (PM), holds the potential to transform modern medical practice. While significant efforts have been made to ...
We performed a single-institution, retrospective analysis of CGP utilization and treatment patterns in patients with localized PDAC who underwent curative-intent resection in the contemporary period ...
CEO Yu-Hsin Lin highlighted the completion of Phase III PHOENIX trial enrollment with 530 subjects for geographic atrophy and the completion of the Phase III DRAGON trial for Stargardt's disease, ...